Catherine Rogers Murray, MPH

Exponent, Inc.

Poster(s):

• (C-233) Emulating a Clinical Trial to Assess the Fitness of Real-World Data for Evaluating the Cardiovascular Safety of Fixed-Dose Combination Naltrexone/Bupropion in the United States
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET